260 related articles for article (PubMed ID: 27940017)
1. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
2. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
Ishikawa C; Arbiser JL; Mori N
Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
[TBL] [Abstract][Full Text] [Related]
3. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
4. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
5. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
[TBL] [Abstract][Full Text] [Related]
6. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
7. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM
Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of honokiol-induced cytotoxicity in thyroid cancer cells.
Chou HC; Lu CH; Su YC; Lin LH; Yu HI; Chuang HH; Tsai YT; Liao EC; Wei YS; Yang YT; Chien YA; Yu XR; Lee YR; Chan HL
Life Sci; 2018 Aug; 207():184-204. PubMed ID: 29883720
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
12. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
13. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
Zhao M; Zheng YH; Zhao QY; Zheng W; Yang JH; Pei HY; Liu L; Liu KJ; Xue LL; Deng DX; Wang L; Ma X; Fu SH; Peng AH; Tang MH; Luo YZ; Ye HY; Chen LJ
Eur J Med Chem; 2021 Jan; 209():112922. PubMed ID: 33069436
[TBL] [Abstract][Full Text] [Related]
15. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
[TBL] [Abstract][Full Text] [Related]
16. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.
Prasad R; Katiyar SK
Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820
[TBL] [Abstract][Full Text] [Related]
17. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Lee B; Kim CH; Moon SK
FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
[TBL] [Abstract][Full Text] [Related]
18. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
[TBL] [Abstract][Full Text] [Related]
20. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
